| 2D-GE | Two-dimensional gel electrophoresis |
| CAFs | Cancer-associated fibroblasts |
| CE-MS | Capillary electrophoresis–mass spectrometry |
| DIA | Data-independent acquisition |
| DMFS | Decayed, missing, and filled surfaces |
| EMT | Epithelial–mesenchymal transition |
| EVs | Extracellular vesicles |
| GC-MS | Gas chromatography-mass spectrometry |
| GCF | Gingival crevicular fluid |
| GWAS | Genome-wide association study(s) |
| iTRAQ | Isobaric tags for relative and absolute quantitation |
| LC-MS/MS | Liquid chromatography coupled to tandem mass spectrometry |
| LFQ | Label-free quantification |
| lncRNA | Long non-coding RNA |
| MDSCs | Myeloid-derived suppressor cells |
| miRNA | MicroRNA |
| MMPg | Mucous membrane pemphigoid |
| mRNA | Messenger RNA |
| MS | Mass spectrometry |
| NGS | Next-generation sequencing |
| NMR | Nuclear magnetic resonance |
| OSCC | Oral squamous cell carcinoma |
| p-EMT | Partial epithelial–mesenchymal transition |
| PCA | Principal component analysis |
| PLS-DA | Partial least squares discriminant analysis |
| PRS | Polygenic risk score |
| PV | Pemphigus vulgaris |
| RNA-seq | RNA sequencing |
| SCFAs | Short-chain fatty acids |
| scRNA-seq | Single-cell RNA sequencing |
| SS | Sjögren’s syndrome |
| SWATH-MS | Sequential window acquisition of all theoretical mass spectra |
| TCA | Tricarboxylic acid cycle |
| TILs | Tumor-infiltrating lymphocytes |
| TME | Tumor microenvironment |
| TMT | Tandem mass tags |
| UPLC-MS | Ultra-performance liquid chromatography-mass spectrometry |
| WES | Whole-exome sequencing |